POLY 25 |
| The introduction of drug eluting stent technology into the interventional cardiac catheter lab has provided a revolutionary new treatment for cardiovascular re-stenosis. Currently, drug eluting coronary stent technologies are widely available and have demonstrated outstanding results in controlled clinical trials. Drug eluting stents consist of a metal scaffold that is coated with a therapeutic agent dispersed in a polymer that serves to modulate the release of the drug to the artery wall. The requirements for the polymer coating include biocompatibility, biostability as well as mechanical integrity. This presentation will highlight various commercial approaches that have been used to engineer polymer coatings to develop effective solutions to treat coronary artery disease. |
|
Polymer Science of Everyday Things
8:25 AM-12:00 PM, Sunday, August 19, 2007 Westin Boston Waterfront -- Otis, Oral
Division of Polymer Chemistry |